← Back to India
IN

Dr. Reddy's Laboratories Limited

DRREDDY · NSE · Pharmaceuticals · Generics and Specialty Drugs · US listing: RDY

Dr. Reddy's Laboratories Limited is number 49 by indicative market capitalization among the 50 listed companies tracked here for India (data year 2024).

About the company

Dr. Reddy's Laboratories is one of India's largest pharmaceutical companies, with a significant generics business in the United States and branded formulations across India, Russia, and other markets. The company is involved in active pharmaceutical ingredient (API) manufacturing and has a growing biosimilars pipeline. Dr. Reddy's is listed on both Indian exchanges and the NYSE.

ExchangeNSE
TickerDRREDDY
SectorPharmaceuticals · Generics and Specialty Drugs
US listingRDY
Indicative market cap USD$12.00B
WebsiteVisit website

Live quote

Loading live price…

Where to buy

Trades in the US as RDY, available through most US brokerage accounts.

On its home market (NSE), it is accessible through global brokers that offer that exchange:

Availability information only. Not a recommendation or an offer to buy. Confirm eligibility, fees and current availability with your broker.

Other ways to get exposure

A US-listed depositary receipt trades as RDY. (Dr. Reddy's is listed on the NYSE and gives US investors exposure to one of India's leading generics pharmaceutical companies, with…) US-listed ADRs & cross-listings →

Single-country ETFs covering India (a fund may or may not hold this company; check its holdings):

Other companies in India

Reliance Industries Limited$221.00BHDFC Bank Limited$178.00BBharti Airtel Limited$134.00BTata Consultancy Services Limited$125.00BICICI Bank Limited$119.00BState Bank of India$100.00BInfosys Limited$80.00BBajaj Finance Limited$73.00B

Company data and any live price are indicative, may be delayed or inaccurate, and are for research only. Not investment advice. Verify with the exchange, the company's filings and your broker. Report an error

Theme